Literature DB >> 7056138

Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel.

K E Blake, M H Dalbow, J P Concannon, S E Hodgson, G J Brodmerkel, A H Panahandeh, K Zimmerman, J J Headings.   

Abstract

Preoperative levels of perchloric acid extractable plasma CEA were measured in 911 patients with complaints of the digestive system. A final diagnosis of benign disease was made for 579 patients; 332 patients were found to have cancer. Data for the preoperative CEA values were examined for clinical significance as an aide to diagnosis, preoperative disease staging, and prognosis. The results of our analysis support the conclusions of many investigators that the CEA assay is not a clinically useful diagnostic test, but it shows limited value in preoperative staging and a somewhat stronger correlation with prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056138     DOI: 10.1007/bf02553544

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.

Authors:  Kristina Schee; Kjersti Flatmark; Ruth Holm; Kjetil Boye; Elisabeth Paus
Journal:  Tumour Biol       Date:  2011-10-18

2.  Expression and immunogenicity of NY-ESO-1 in colorectal cancer.

Authors:  Ya Li; Ruifeng Song; Xinqiang Li; Feng Xu
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

Review 3.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Carcinoembryonic antigen (CEA) in human colorectal cancers growing subcutaneously in nude mice.

Authors:  H H Fiebig; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  The clinicopathologic features of serum CA 19-9-positive colorectal cancers.

Authors:  T Ueda; E Shimada; T Urakawa
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.

Authors:  Christian P Probst; Adan Z Becerra; Christopher T Aquina; Mohamedtaki A Tejani; Bradley J Hensley; Maynor G González; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  J Gastrointest Surg       Date:  2015-11-06       Impact factor: 3.452

7.  Colorectal cancer biomarkers and the potential role of cancer stem cells.

Authors:  Russell C Langan; John E Mullinax; Manish T Raiji; Trevor Upham; Thomas Summers; Alexander Stojadinovic; Itzhak Avital
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

8.  Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.

Authors:  Bilal Alaiyan; Nadia Ilyayev; Alexander Stojadinovic; Mina Izadjoo; Marina Roistacher; Vera Pavlov; Victoria Tzivin; David Halle; Honguang Pan; Barry Trink; Ali O Gure; Aviram Nissan
Journal:  BMC Cancer       Date:  2013-04-17       Impact factor: 4.430

9.  Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer.

Authors:  M Li; J-Y Li; A-L Zhao; J-S He; L-X Zhou; Y-A Li; J Gu
Journal:  Colorectal Dis       Date:  2008-05-29       Impact factor: 3.788

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.